Ruiz-Ortega M, Rodrigues-Diez RR, Lavoz C, et al. Special Issue "Diabetic Nephropathy: Diagnosis, Prevention and Treatment"[J]. J Clin Med, 2020, 9(3): 813.
糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志,2021,37(3):266-268.
Agrawal L, Azad N, Bahn GD, et al. Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)[J]. Diabetologia, 2018, 61(2): 295-299.
National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update[J]. Am J Kidney Dis, 2012,60(5): 850-886.
Mann JFE, Ørsted DD, Brown-Frandsen K, et al. Liraglutideand renal outcomes in type 2 diabetes[J]. N Engl J Med, 2017,377(9): 839-848.
Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1.Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 2017, 38(32): 2459-2472.